Portola Pharmaceuticals, Inc. Operating Cash Flow
Portola Pharmaceuticals, Inc. reported Operating Cash Flow of -$71.10 million for the 3-month period ending 2020-03-31, per its 10-Q filed 2020-05-11.
Discontinued › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2020-05-11
- Portola Pharmaceuticals, Inc. net cash provided by (used in) operating activities for the quarter ending 2020-03-31 was -$71.10M.
- Portola Pharmaceuticals, Inc. net cash provided by (used in) operating activities for the quarter ending 2019-12-31 was -$73.34M.
- Portola Pharmaceuticals, Inc. net cash provided by (used in) operating activities for the quarter ending 2019-09-30 was -$46.88M.
- Portola Pharmaceuticals, Inc. net cash provided by (used in) operating activities for the quarter ending 2019-06-30 was -$54.06M.
- Portola Pharmaceuticals, Inc. net cash provided by (used in) operating activities for fiscal 2019 was -$237.92M.
- Portola Pharmaceuticals, Inc. net cash provided by (used in) operating activities for fiscal 2018 was -$326.06M.
- Portola Pharmaceuticals, Inc. net cash provided by (used in) operating activities for fiscal 2017 was -$225.13M.
- Portola Pharmaceuticals, Inc. net cash provided by (used in) operating activities for fiscal 2016 was -$196.46M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|
| 2020-03-31 | -$71.10M 10-Q · filed 2020-05-11 | -$144.44M derived: sum of 2 quarters · filed 2020-05-11 | -$191.32M derived: sum of 3 quarters · filed 2020-05-11 | -$245.39M derived: sum of 4 quarters · filed 2020-05-11 |
| 2019-12-31 | -$73.34M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28 | -$120.22M derived: sum of 2 quarters · filed 2020-02-28 | -$174.29M derived: sum of 3 quarters · filed 2020-02-28 | -$237.92M 10-K · filed 2020-02-28 |
| 2019-09-30 | -$46.88M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | -$100.95M derived: sum of 2 quarters · filed 2019-11-05 | -$164.59M 10-Q · filed 2019-11-05 | -$227.97M derived: sum of 4 quarters · filed 2020-05-11 |
| 2019-06-30 | -$54.06M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | -$117.70M 10-Q · filed 2019-08-07 | -$181.08M derived: sum of 3 quarters · filed 2020-05-11 | -$263.45M derived: sum of 4 quarters · filed 2020-05-11 |
| 2019-03-31 | -$63.63M 10-Q · filed 2020-05-11 | -$127.02M derived: sum of 2 quarters · filed 2020-05-11 | -$209.38M derived: sum of 3 quarters · filed 2020-05-11 | -$301.27M derived: sum of 4 quarters · filed 2020-05-11 |
| 2018-12-31 | -$63.38M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28 | -$145.75M derived: sum of 2 quarters · filed 2020-02-28 | -$237.64M derived: sum of 3 quarters · filed 2020-02-28 | -$326.06M 10-K · filed 2020-02-28 |
| 2018-09-30 | -$82.37M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | -$174.26M derived: sum of 2 quarters · filed 2019-11-05 | -$262.68M 10-Q · filed 2019-11-05 | -$328.39M derived: sum of 4 quarters · filed 2020-02-28 |
| 2018-06-30 | -$91.89M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | -$180.31M 10-Q · filed 2019-08-07 | -$246.02M derived: sum of 3 quarters · filed 2020-02-28 | -$304.90M derived: sum of 4 quarters · filed 2020-02-28 |
| 2018-03-31 | -$88.42M 10-Q · filed 2019-05-08 | -$154.13M derived: sum of 2 quarters · filed 2020-02-28 | -$213.01M derived: sum of 3 quarters · filed 2020-02-28 | |
| 2017-12-31 | -$65.71M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28 | -$124.59M derived: sum of 2 quarters · filed 2020-02-28 | -$225.13M 10-K · filed 2020-02-28 | |
| 2017-09-30 | -$58.88M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | -$159.41M 10-Q · filed 2018-11-07 | ||
| 2017-06-30 | -$100.53M 10-Q · filed 2018-08-09 | |||
| 2016-12-31 | -$196.46M 10-K · filed 2019-03-01 | |||
| 2013-12-31 | -$20.71M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-03 | -$34.29M derived: sum of 2 quarters · filed 2014-03-03 | -$63.62M 10-K · filed 2014-03-03 | |
| 2013-09-30 | -$13.58M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-06 | -$42.91M 10-Q · filed 2013-11-06 | ||
| 2013-06-30 | -$29.33M 10-Q · filed 2013-08-14 | |||
| 2012-12-31 | -$4.90M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-03 | -$21.66M derived: sum of 2 quarters · filed 2014-03-03 | -$49.23M 10-K · filed 2014-03-03 | |
| 2012-09-30 | -$16.76M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-06 | -$44.32M 10-Q · filed 2013-11-06 | ||
| 2012-06-30 | -$27.56M 10-Q · filed 2013-08-14 | |||
| 2011-12-31 | -$11.32M 10-K · filed 2014-03-03 |